Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021513
Filing Date
2022-11-03
Accepted
2022-11-03 06:47:52
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-20220930.htm   iXBRL 10-Q 2519011
2 EX-31.1 krtx-ex31_1.htm EX-31.1 18254
3 EX-31.2 krtx-ex31_2.htm EX-31.2 18237
4 EX-32.1 krtx-ex32_1.htm EX-32.1 18453
  Complete submission text file 0000950170-22-021513.txt   8308745

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krtx-20220930_lab.xml EX-101.LAB 412466
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krtx-20220930_def.xml EX-101.DEF 145294
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krtx-20220930_pre.xml EX-101.PRE 286241
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krtx-20220930.xsd EX-101.SCH 53304
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krtx-20220930_cal.xml EX-101.CAL 58394
52 EXTRACTED XBRL INSTANCE DOCUMENT krtx-20220930_htm.xml XML 1566950
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 221356064
SIC: 2834 Pharmaceutical Preparations